206 related articles for article (PubMed ID: 12044243)
1. p53 Gene therapy for lung cancer.
Swisher SG; Roth JA
Curr Oncol Rep; 2002 Jul; 4(4):334-40. PubMed ID: 12044243
[TBL] [Abstract][Full Text] [Related]
2. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
Swisher SG; Roth JA; Komaki R; Gu J; Lee JJ; Hicks M; Ro JY; Hong WK; Merritt JA; Ahrar K; Atkinson NE; Correa AM; Dolormente M; Dreiling L; El-Naggar AK; Fossella F; Francisco R; Glisson B; Grammer S; Herbst R; Huaringa A; Kemp B; Khuri FR; Kurie JM; Liao Z; McDonnell TJ; Morice R; Morello F; Munden R; Papadimitrakopoulou V; Pisters KM; Putnam JB; Sarabia AJ; Shelton T; Stevens C; Shin DM; Smythe WR; Vaporciyan AA; Walsh GL; Yin M
Clin Cancer Res; 2003 Jan; 9(1):93-101. PubMed ID: 12538456
[TBL] [Abstract][Full Text] [Related]
3. Clinical update of Ad-p53 gene therapy for lung cancer.
Swisher SG; Roth JA
Surg Oncol Clin N Am; 2002 Jul; 11(3):521-35. PubMed ID: 12487055
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.
Swisher SG; Roth JA; Nemunaitis J; Lawrence DD; Kemp BL; Carrasco CH; Connors DG; El-Naggar AK; Fossella F; Glisson BS; Hong WK; Khuri FR; Kurie JM; Lee JJ; Lee JS; Mack M; Merritt JA; Nguyen DM; Nesbitt JC; Perez-Soler R; Pisters KM; Putnam JB; Richli WR; Savin M; Schrump DS; Shin DM; Shulkin A; Walsh GL; Wait J; Weill D; Waugh MK
J Natl Cancer Inst; 1999 May; 91(9):763-71. PubMed ID: 10328106
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer.
Schuler M; Rochlitz C; Horowitz JA; Schlegel J; Perruchoud AP; Kommoss F; Bolliger CT; Kauczor HU; Dalquen P; Fritz MA; Swanson S; Herrmann R; Huber C
Hum Gene Ther; 1998 Sep; 9(14):2075-82. PubMed ID: 9759934
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of adenoviral mediated p53 gene therapy for non-small cell lung cancer in Japan].
Kagawa S; Fujiwara T; Tanaka N
Gan To Kagaku Ryoho; 2003 Feb; 30(2):193-7. PubMed ID: 12610865
[TBL] [Abstract][Full Text] [Related]
7. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK; Khurl FR; Kurie JM; Nesbitt JC; Pisters K; Putnam JB; Schrump DS; Shin DM; Walsh GL
Semin Oncol; 1998 Jun; 25(3 Suppl 8):33-7. PubMed ID: 9704675
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
10. p53 tumor suppressor gene therapy for cancer.
Roth JA; Swisher SG; Meyn RE
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
[TBL] [Abstract][Full Text] [Related]
11. CT-guided intratumoral gene therapy in non-small-cell lung cancer.
Kauczor HU; Schuler M; Heussel CP; von Weymarn A; Bongartz G; Rochlitz C; Huber C; Thelen M
Eur Radiol; 1999; 9(2):292-6. PubMed ID: 10101653
[TBL] [Abstract][Full Text] [Related]
12. [A phase I trial of adenoviral p53 gene therapy for non-small cell lung cancer].
Fujiwara T; Kataoka M; Kawamata O; Tanaka N
Nihon Geka Gakkai Zasshi; 1999 Nov; 100(11):749-55. PubMed ID: 10629843
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy in lung cancer.
Swisher SG; Roth JA
Curr Oncol Rep; 2000 Jan; 2(1):64-70. PubMed ID: 11122826
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study.
Schuler M; Herrmann R; De Greve JL; Stewart AK; Gatzemeier U; Stewart DJ; Laufman L; Gralla R; Kuball J; Buhl R; Heussel CP; Kommoss F; Perruchoud AP; Shepherd FA; Fritz MA; Horowitz JA; Huber C; Rochlitz C
J Clin Oncol; 2001 Mar; 19(6):1750-8. PubMed ID: 11251006
[TBL] [Abstract][Full Text] [Related]
15. Gene replacement strategies for lung cancer.
Roth JA
Curr Opin Oncol; 1998 Mar; 10(2):127-32. PubMed ID: 9555535
[TBL] [Abstract][Full Text] [Related]
16. [Adenoviral p53 gene therapy for human lung cancer].
Fujiwara T; Tanaka N
Gan To Kagaku Ryoho; 2003 Apr; 30(4):460-7. PubMed ID: 12722675
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral gene therapy for non-small cell lung cancer: current status and future directions.
Neyns B; Noppen M
Monaldi Arch Chest Dis; 2003; 59(4):287-95. PubMed ID: 15148838
[TBL] [Abstract][Full Text] [Related]
18. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
[TBL] [Abstract][Full Text] [Related]
19. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C
Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
[TBL] [Abstract][Full Text] [Related]
20. Gene replacement strategies for treating non-small cell lung cancer.
Roth JA; Grammer SF; Swisher SG; Nemunaitis J; Merritt J; Meyn RE
Semin Radiat Oncol; 2000 Oct; 10(4):333-42. PubMed ID: 11040334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
